サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541653

感染管理市場レポート：タイプ別、エンドユーザー別、地域別、2024～2032年

Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
感染管理市場レポート：タイプ別、エンドユーザー別、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染管理市場規模は2023年に264億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに475億米ドルに達し、2024～2032年の間に6.5％の成長率（CAGR）を示すと予測しています。診断・感染管理機器の急速な技術進歩、獣医・動物医療現場での需要の増加、感染症予防の研究開発の高まり、医療関連感染（HAI）予防への関心の高まりなどが、市場を後押しする要因のひとつです。

感染管理は、医療施設、公共スペース、職場など、さまざまな環境における感染症の蔓延と伝播を防止するために実施される重要な一連の対策と慣行です。主要目的は、個人、患者、医療従事者を感染症の発症や蔓延から守ることです。医療環境では、手指衛生、個人防護具（PPE）の使用、医療器具の適切な滅菌・消毒、伝染性患者に対する隔離予防措置などの厳格なプロトコルが必要となります。これらの対策により、医療関連感染のリスクを低減し、患者の安全を確保します。公共スペースや職場においては、感染防止対策として、定期的な清掃や表面の消毒、呼吸器衛生の推進、伝染病の蔓延を防ぐためのワクチン接種の奨励などが挙げられます。感染管理は、感染症の発生を食い止め、感染症の影響を緩和し、公衆衛生を維持する上で極めて重要な役割を担っています。これは、医療専門家、政策立案者、個人を巻き込んだ協力的な取り組みであり、地域社会の福利を守り、感染症の伝播を防ぐために、意識、教育、ベストプラクティスの遵守が重要であることを強調しています。

世界市場は、感染症の流行の増加が主要要因となっています。これに伴い、世界人口の増加と都市化が市場に大きく寄与しています。さらに、院内感染の増加が市場にプラスの影響を与えています。これとは別に、薬剤耐性病原体の出現や、医療施設における厳格な対策に対する需要の高まりが、市場を活性化しています。感染制御プロトコルを義務付ける世界各国の政府規制が、市場に明るい展望をもたらしています。さらに、患者の安全に対する関心の高まりや、公共の場での感染に対する意識の高まりが市場を活性化しています。加えて、感染症にかかりやすい高齢化人口の増加が市場を後押ししています。さらに、感染制御技術や製品の急速な進歩が市場を後押ししています。市場を牽引するその他の要因としては、医療インフラの拡大、医療費の増加、歯科・外科手術のニーズの高まりなどが挙げられます。

感染管理市場傾向/促進要因

手術件数と医療処置件数の増加

手術件数と医療処置件数の増加が市場を強化しています。医療の進歩が進むにつれ、健康状態に効果的に対処するためのさまざまな外科的介入や侵襲的処置に対する需要が高まっています。こうした処置の増加に伴い、医療関連感染（HAI）のリスクも高まっており、医療現場における感染制御プロトコルの重要性が浮き彫りになっています。手術部位は特に感染に対して脆弱であり、医療施設は合併症のリスクを最小限に抑え、患者の安全を確保するために厳格な対策を実施しなければならないです。厳重な手指衛生、器具の適切な滅菌、隔離予防策の遵守などの管理方法は、感染を予防し、転帰を成功に導く上で極めて重要な役割を果たします。手術や医療処置の件数が世界的に増加するにつれ、製品や技術に対する需要も拡大すると予想されます。メーカーや医療プロバイダーは、こうした重要な手術の際に感染リスクを効果的に管理し、患者ケアを強化するための革新的なソリューションを継続的に模索しています。

食品加工産業での採用拡大

食品加工産業における感染管理対策の採用拡大が市場を促進しています。食品加工施設は大量の食品を扱い、加工するため、汚染や感染拡大の影響を受けやすいです。食品の安全性を確保し、食中毒の発生を防ぐには、厳格な感染管理対策が不可欠です。食品加工産業におけるこれらの管理対策には、衛生状態の維持、厳格な清掃・衛生プロトコルの実施、衛生習慣に関する従業員のトレーニングなどが含まれます。これらの対策は、食中毒の原因となる有害な細菌、ウイルス、その他の病原体の増殖を防ぐのに役立ちます。食品の安全性と規制遵守への注目が高まる中、食品加工企業は効果的なソリューションへの投資の重要性を認識しています。汚染のリスクを低減し、安全な食品加工を保証する技術や製品に対する需要は増加傾向にあり、このセグメントの市場成長に拍車をかけています。

感染予防に対する医療専門家の意識の高まり

感染予防に関する医療専門家の意識の高まりは、市場に明るい展望をもたらしています。医師、看護師、その他の医療スタッフを含む医療専門家は、患者のケアと安全において極めて重要な役割を果たしています。感染症やその感染様式に対する理解が深まるにつれ、医療専門家は感染予防プロトコルの実施に積極的になっています。医療現場では、感染症に効果的に対処するための知識とスキルを医療スタッフに身につけさせるための啓発プログラム、トレーニングセッション、継続教育の取り組みが一般的になっています。このような取り組みでは、手指衛生、個人防護具（PPE）の適切な使用、滅菌・消毒の実践、隔離予防策の遵守に重点が置かれています。患者の安全性と質の高い医療が重視されるようになり、医療施設では感染対策を標準業務手順の不可欠な要素として優先するようになっています。患者の安全を確保し、医療関連感染（HAI）を予防しながら最善のケアを提供しようと医療施設が努力する中、医療従事者のこのような意識の高まりが、感染制御製品、技術、プロトコルに対する需要を後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の感染管理市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 装置
    • 市場動向
    • 主要タイプ
      • 消毒剤
        • ワッシャー
        • フラッシャー
        • 超音波洗浄機
      • 滅菌装置
        • 加熱殺菌
        • 低温殺菌
        • 放射線滅菌
        • 濾過滅菌
      • その他
    • 市場予測
  • サービス
    • 市場動向
    • 主要タイプ
      • 契約不妊手術
        • ETO滅菌
        • ガンマ線滅菌
        • 電子ビーム滅菌
        • 蒸気滅菌
      • 感染性廃棄物の処分
    • 市場予測
  • 消耗品
    • 市場動向
    • 主要タイプ
      • 消毒剤
      • 滅菌消耗品
      • 個人用保護具
      • その他
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 病院とクリニック
  • 医療機器企業
  • 臨床試験室
  • 製薬会社
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Advanced Sterlization Products Services Inc.（Fortive Corporation）
    • Belimed AG（Metall Zug）
    • Cantel Medical Corp.
    • Getinge AB
    • Matachana
    • Metrex Research LLC（Envista Holdings and Sybron Dental Specialities Inc）
    • MMM Munchener Medizin Mechanik GmbH
    • Pal International
    • Sterigenics U.S. LLC（Sotera Health Holdings LLC）
    • Steris Corporation
    • TSO3 Inc.（Stryker Corporation）
図表

List of Figures

  • Figure 1: Global: Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Control Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Infection Control Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Infection Control Market: Breakup by End User (in %), 2023
  • Figure 5: Global: Infection Control Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Infection Control Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Infection Control (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Infection Control (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Infection Control (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Infection Control (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Infection Control (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Infection Control (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Infection Control (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Infection Control (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Infection Control (Medical Device Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Infection Control (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Infection Control (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Infection Control (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Infection Control (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Infection Control (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Infection Control (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Infection Control (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: North America: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: North America: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: United States: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: United States: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Canada: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Canada: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Asia Pacific: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Asia Pacific: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: China: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: China: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Japan: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Japan: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: India: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: India: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: South Korea: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: South Korea: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Australia: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Australia: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Indonesia: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Indonesia: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Others: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Others: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Europe: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Europe: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Germany: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Germany: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: France: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: France: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United Kingdom: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United Kingdom: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Italy: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Italy: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Spain: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Spain: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Russia: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Russia: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Brazil: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Brazil: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Mexico: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Mexico: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Infection Control Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Middle East and Africa: Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Infection Control Industry: SWOT Analysis
  • Figure 72: Global: Infection Control Industry: Value Chain Analysis
  • Figure 73: Global: Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Control Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Infection Control Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Infection Control Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Infection Control Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Infection Control Market: Competitive Structure
  • Table 6: Global: Infection Control Market: Key Players
目次
Product Code: SR112024A2509

The global infection control market size reached US$ 26.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 47.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032. The rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, the rising research and development in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market.

Infection control is a crucial set of measures and practices implemented to prevent the spread and transmission of infections in various settings, including healthcare facilities, public spaces, and workplaces. The primary goal is to protect individuals, patients, and healthcare workers from acquiring and spreading infectious diseases. In healthcare settings, it involves strict protocols for hand hygiene, using personal protective equipment (PPE), proper sterilization and disinfection of medical equipment, and isolation precautions for contagious patients. These measures reduce the risk of healthcare-associated infections and ensure patient safety. In public spaces and workplaces, infection control measures may include regular cleaning and disinfecting surfaces, promoting respiratory hygiene, and encouraging vaccination to prevent the spreading of communicable diseases. It plays a pivotal role in containing outbreaks, mitigating the impact of infectious diseases, and maintaining public health. It is a collaborative effort involving healthcare professionals, policymakers, and individuals, emphasizing the importance of awareness, education, and adherence to best practices to safeguard the well-being of communities and prevent the transmission of infections.

The global market is majorly driven by the increasing prevalence of infectious diseases. In line with this, the growing global population and urbanization are significantly contributing to the market. Furthermore, the rise in hospital-acquired infections is positively influencing the market. Apart from this, the emergence of drug-resistant pathogens and the escalating demand for stringent these measures in healthcare facilities are catalyzing the market. Several governments worldwide regulations mandating infection control protocols are creating a positive outlook for the market. Moreover, the increasing focus on patient safety and the rising awareness of infection transmission in public spaces are catalyzing the market. Besides, the growing aging population, susceptible to infection, is propelling the market. Additionally, the rapid advances in infection control technologies and products are providing a boost to the market. Other factors driving the market include expanding healthcare infrastructure, escalating healthcare expenditure, and the increasing need in dental and surgical procedures.

Infection Control Market Trends/Drivers:

Rising number of surgeries and medical procedures

The rising number of surgeries and medical procedures is bolstering the market. As medical advancements continue, there is a growing demand for various surgical interventions and invasive procedures to address health conditions effectively. With an increase in these procedures, the risk of healthcare-associated infections (HAIs) also escalates, highlighting the critical importance of infection control protocols in healthcare settings. Surgical sites are particularly vulnerable to infections, and healthcare facilities must implement stringent measures to minimize the risk of complications and ensure patient safety. The control practices, including strict hand hygiene, proper sterilization of instruments, and adherence to isolation precautions, play a pivotal role in preventing infections and promoting successful outcomes. As the volume of surgeries and medical procedures rises globally, the demand for products and technologies is expected to grow. Manufacturers and healthcare providers continuously explore innovative solutions to effectively manage infection risks and enhance patient care during these essential interventions.

Growing adoption in food processing industries

The growing adoption of infection control measures in food processing industries is fostering the market. Food processing facilities handle and process large quantities of food products, making them susceptible to contamination and spreading infections. Strict infection control practices are imperative to ensure food safety and prevent outbreaks of foodborne illnesses. These control measures in food processing industries include maintaining hygienic conditions, implementing rigorous cleaning and sanitation protocols, and training employees on hygiene practices. These measures help prevent the growth of harmful bacteria, viruses, and other pathogens that can cause foodborne illnesses. With an increasing focus on food safety and regulatory compliance, food processing companies are recognizing the importance of investing in effective solutions. The demand for technologies and products that can reduce the risk of contamination and ensure safe food processing is on the rise, fueling the market growth in this sector.

Increasing awareness among healthcare professionals about infection prevention

The increasing awareness among healthcare professionals about infection prevention is creating a positive outlook for the market. Healthcare professionals, including doctors, nurses, and other medical staff, play a pivotal role in patient care and safety. As the understanding of infectious diseases and their modes of transmission improves, healthcare professionals are becoming more proactive in implementing infection prevention protocols. Awareness programs, training sessions, and continuing education initiatives have become common in healthcare settings to equip medical staff with the knowledge and skills to combat infections effectively. These efforts focus on hand hygiene, proper use of personal protective equipment (PPE), sterilization and disinfection practices, and adherence to isolation precautions. With a growing emphasis on patient safety and quality healthcare, healthcare facilities are prioritizing infection control measures as an integral part of their standard operating procedures. This heightened awareness among healthcare professionals drives the demand for infection control products, technologies, and protocols, as healthcare facilities strive to provide the best possible care while ensuring patient safety and preventing healthcare-associated infections (HAIs).

Infection Control Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global infection control market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type and end user.

Breakup by Type:

Equipment

Disinfectors

Washers

Flushers

Ultrasonic Cleaners

Sterilization Equipment

Heat Sterilization

Low Temperature Sterilization

Radiation Sterilization

Filtration-Based Sterilization

Others

Services

Contract Sterilization

ETO Sterilization

Gamma Sterilization

E-Beam Sterilization

Steam Sterilization

Infectious Waste Disposal

Consumables

Disinfectants

Sterilization Consumables

Personal Protective Equipment

Others

Consumables dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes equipment, services, and consumables. According to the report, consumables represented the largest segment.

The consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

In the wake of the COVID-19 pandemic, the demand for PPE, including masks, gloves, and gowns, has increased significantly to protect healthcare workers and the general public from viral transmission. The consumables segment's dominance is attributed to the ongoing need for these essential infection control products in various industries and the growing emphasis on health and safety across the globe. As the awareness of infection prevention continues to increase, the demand for consumables is expected to sustain its market leadership.

Breakup by End User:

Hospitals and Clinics

Medical Device Companies

Clinical Laboratories

Pharmaceutical Companies

Others

Hospitals and clinics dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, medical device companies, clinical laboratories, pharmaceutical companies, and others. According to the report, hospitals and clinics represented the largest segment.

The hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment.

With a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includeS North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures, as older adults are more susceptible to infections and require enhanced healthcare support. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

High healthcare expenditure in the region also plays a pivotal role in driving the market, as healthcare facilities and providers prioritize patient safety and infection prevention to improve healthcare outcomes. Additionally, stringent regulatory guidelines and a focus on quality healthcare practices encourage institutions to invest in infection control products and protocols.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

3M Company

Advanced Sterlization Products Services Inc. (Fortive Corporation)

Belimed AG (Metall Zug)

Cantel Medical Corp.

Getinge AB

Matachana

Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)

MMM Munchener Medizin Mechanik GmbH

Pal International

Sterigenics U.S. LLC (Sotera Health Holdings LLC)

Steris Corporation

TSO3 Inc. (Stryker Corporation)

Recent Developments:

In 2018, 3M Healthcare collaborated with BD (Becton, Dickinson, and Company) to create and launch the 3M Attest Rapid Readout Biological Indicator System for vaporized hydrogen peroxide sterilization. This collaboration aimed to provide healthcare facilities with a faster and more reliable method to verify sterilization efficacy, contributing to improved infection control practices.

In 2019, Fortive Corporation, the parent company of Advanced Sterilization Products (ASP), acquired the laboratory water purification business from Danaher Corporation, a strategic move to expand its life sciences portfolio. While this acquisition does not directly involve infection control, it showcases Fortive's commitment to growing its capabilities in the healthcare and life sciences sectors.

In 2020, Belimed AG, a global provider of infection control solutions, introduced the MST-V 6060, a steam sterilizer designed for small and medium-sized practices. This innovation offered healthcare professionals a cost-effective and efficient sterilization solution to enhance infection prevention in smaller healthcare facilities.

Key Questions Answered in This Report:

  • How has the global infection control market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global infection control market?
  • What is the impact of each driver, restraint, and opportunity on the global infection control market?
  • What are the key regional markets?
  • Which countries represent the most attractive infection control market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global infection control market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global infection control market?
  • What is the competitive structure of the global infection control market?
  • Who are the key players/companies in the global infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Disinfectors
        • 6.1.2.1.1 Washers
        • 6.1.2.1.2 Flushers
        • 6.1.2.1.3 Ultrasonic Cleaners
      • 6.1.2.2 Sterilization Equipment
        • 6.1.2.2.1 Heat Sterilization
        • 6.1.2.2.2 Low Temperature Sterilization
        • 6.1.2.2.3 Radiation Sterilization
        • 6.1.2.2.4 Filtration-Based Sterilization
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Contract Sterilization
        • 6.2.2.1.1 ETO Sterilization
        • 6.2.2.1.2 Gamma Sterilization
        • 6.2.2.1.3 E-Beam Sterilization
        • 6.2.2.1.4 Steam Sterilization
      • 6.2.2.2 Infectious Waste Disposal
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Disinfectants
      • 6.3.2.2 Sterilization Consumables
      • 6.3.2.3 Personal Protective Equipment
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Device Companies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinical Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Advanced Sterlization Products Services Inc. (Fortive Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Belimed AG (Metall Zug)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cantel Medical Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Getinge AB
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Matachana
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 MMM Munchener Medizin Mechanik GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Pal International
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Sterigenics U.S. LLC (Sotera Health Holdings LLC)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Steris Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 TSO3 Inc. (Stryker Corporation)
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio